Read the claim. Check the record.

Our September 26, 2026 edition uses current public provider materials alongside FDA, American Academy of Dermatology and DailyMed information. TinyFish search and page retrieval supported research; expanded provider-page details were inspected where collapsed text mattered.

Four questions, consistently asked

What is in the product? What is payable and for which period? What happens on a future order? What still needs a personal answer? The shortlist presents these fields for every provider, with source links.

Evidence stays attached to the right claim

A product page supports a statement about a public offer, not an independent effectiveness conclusion. A company review is not necessarily a cream review. Evidence about hydroquinone or a particular approved combination does not establish the performance of a different branded preparation.

No manufactured score

We have not conducted a product trial, verified patient outcomes, inspected pharmacies or performed a head-to-head comparison. We assign no numerical medical ratings. CoreAge Rx is first because that placement is sponsored. The other positions do not imply a clinical hierarchy.

Handle uncertainty explicitly

If a quantity, strength or fee was not established, we say so. A public omission is not proof the provider cannot supply an answer. RedBox’s approval wording is reported as an unresolved claim; an illustrative DailyMed label is not attributed to its actual supply.

Prices retain their units

Monthly equivalents, shipment totals, consultation charges and order-processing fees are recorded separately. Illustrative arithmetic states its assumptions. A current individualized invoice takes precedence over the public figures in our reports.

Dates and sources

Reports show their research date and a source list. The source register explains what each record supports. This edition is a dated review, not a continuously monitored feed. Check current provider information before purchasing.